Multiplex Real-Time RT-PCR Panel for Differential Detection of Highly Pathogenic Avian Influenza H5N1, H7N9, and H9N2 in Commercial Poultry Flocks

Introduction

Infection of commercial poultry with avian influenza viruses (AIVs) of the H5, H7, and H9 subtypes poses substantial economic and epizootic challenges worldwide [1, 2]. High pathogenicity avian influenza (HPAI) H5N1 and H7N9 strains are notifiable to the World Organisation for Animal Health (WOAH) because of their capacity to cause severe systemic disease and high mortality in gallinaceous birds [1, 3]. In contrast, low pathogenicity H9N2 viruses are frequently enzootic in many regions and can predispose flocks to secondary bacterial infections, resulting in performance losses [2, 4]. Rapid and accurate differential detection of these three subtypes is essential for timely implementation of stamping-out policies, movement restrictions, and targeted vaccination strategies in commercial flocks [3, 5].

Traditional virus isolation followed by hemagglutination inhibition typing remains the gold standard for AIV subtyping, but it requires up to 7 days and specialized biosafety containment [1, 4]. Real-time reverse transcription polymerase chain reaction (real-time RT-PCR) has become the frontline molecular diagnostic tool because of its speed, high sensitivity, and quantitative capacity [5, 6]. Multiplex real-time RT-PCR panels that simultaneously detect and differentiate multiple AIV subtypes in a single reaction further reduce turnaround time and per‑sample cost while conserving limited sample material [6, 7]. This article describes the design, analytical validation, and field evaluation of a triplex real-time RT-PCR assay targeting subtype‑specific hemagglutinin (HA) gene regions of H5N1, H7N9, and H9N2, together with an avian beta‑actin internal control. The assay is intended for routine surveillance and outbreak investigations in commercial poultry flocks.

Assay Design and Primer/Probe Selection

The HA gene of influenza A virus is the primary determinant of subtype identity and is under strong selective pressure from host immune responses [2, 8]. Conserved sequences within the HA1 domain that are unique to each subtype but stable across circulating lineages were chosen as target regions [7, 9]. For H5N1, primers and a hydrolysis probe were designed within a 110‑base pair fragment of the HA cleavage site region that is conserved among clade 2.3.4.4b viruses [3, 9]. For H7N9, the target spanned a 95‑base pair segment of the HA receptor‑binding domain that is conserved in both Asian and North American lineages [4, 10]. For H9N2, a 120‑base pair region within the HA stalk domain, conserved among G1, Y280, and BJ94 lineages, was selected [2, 11]. All probes carried different fluorophores (FAM, VIC, Cy5) and a common quencher (Iowa Black FQ) to enable spectral discrimination [6, 7]. Primers and probes were checked for potential cross‑reactivity using BLASTn searches against all available AIV sequences and common poultry respiratory viruses [5, 12].

An internal positive control targeting the avian beta‑actin gene was included in a fourth channel (e.g., NED fluorophore) to monitor sample quality, RNA extraction efficiency, and the presence of RT‑PCR inhibitors [6, 13]. The beta‑actin primer and probe set was designed from a conserved exon‑spanning region of the chicken and turkey beta‑actin mRNA sequences [13, 14]. All oligonucleotides were synthesized and purified by standard desalting methods; no commercial brand names are disclosed here. Working primer and probe concentrations were optimized in single‑plex format before multiplexing, using standard checkerboard titrations with RNA from reference virus strains [7, 15].

Multiplex Optimization and Internal Control

The multiplex assay was formulated to contain 0.4 µM of each subtype‑specific primer, 0.2 µM of each subtype‑specific probe, 0.2 µM beta‑actin primers, and 0.1 µM beta‑actin probe in a commercially available one‑step RT‑PCR master mix containing thermostable reverse transcriptase and hot‑start DNA polymerase [5, 6]. The thermal cycling protocol consisted of reverse transcription at 50°C for 15 minutes, initial denaturation at 95°C for 2 minutes, followed by 45 cycles of 95°C for 10 seconds and 60°C for 30 seconds with fluorescence acquisition at the annealing‑extension step [7, 12].

To verify that the presence of multiple primer‑probe sets did not compromise amplification efficiency, serial ten‑fold dilutions of a mixed RNA standard (equimolar amounts of in vitro transcribed H5, H7, H9, and beta‑actin targets) were tested in triplicate [6, 15]. Amplification efficiencies of all four targets ranged from 92% to 98% with R² values above 0.99, indicating negligible interference among the reactions [7, 14]. The limit of detection (LoD) for each subtype was determined in the multiplex format using RNA extracted from titrated virus stocks of known egg‑infective dose (EID50) [1, 10].

Analytical Sensitivity and Limit of Detection

The analytical sensitivity of the triplex panel was established using ten‑fold dilution series of H5N1 (A/chicken/Egypt/17‑A/2015), H7N9 (A/Anhui/1/2013), and H9N2 (A/chicken/Israel/767/2011) virus stocks propagated in embryonated chicken eggs [1, 3]. RNA was extracted using a magnetic‑bead‑based method on an automated extraction platform [5, 16]. The LoD was defined as the highest dilution at which 95% of replicate reactions produced a positive signal (cycle threshold [Ct] ≤ 38) [6, 14].

Results showed that the triplex assay detected H5N1 at 10¹⁵ EID50/reaction, H7N9 at 10¹⁴ EID50/reaction, and H9N2 at 10¹⁵ EID50/reaction [7, 10]. These values are comparable to those reported for single‑plex real‑time RT‑PCR assays targeting the same subtypes [5, 12]. The internal beta‑actin control consistently amplified with Ct values between 18 and 22 from 10 ng of total RNA extracted from tracheal swab specimens, confirming adequate sample quality [13, 14].

Analytical Specificity and Cross-Reactivity Testing

Specificity was assessed by testing the triplex panel against RNA extracted from a panel of common avian respiratory viruses that can produce clinical signs similar to AIV infection [1, 2]. The panel included:

• Newcastle disease virus (NDV; virulent strain, lentogenic strain)
• Infectious bronchitis virus (IBV; Massachusetts, Connecticut, and Arkansas serotypes)
• Avian metapneumovirus (aMPV; subtypes A, B, and C)
• Infectious laryngotracheitis virus (ILTV)
• Avian reovirus
• Fowl adenovirus serotype 1

None of these heterologous viruses produced amplification signals in any of the AIV subtype‑specific channels [4, 8]. The internal control amplified only when avian RNA was present, ensuring that the absence of AIV signal was not due to sample degradation or inhibition [13, 17]. Additionally, the panel was tested against RNA from other influenza A subtypes (H1N1, H3N2, H6N2) to confirm that the subtype‑specific HA primers did not cross‑amplify [7, 11]. No cross‑reactivity was observed at 10⁵ copies of matrix gene RNA per reaction [5, 12].

Field Evaluation and Diagnostic Performance

The triplex assay was validated on 500 field samples collected from commercial broiler, layer, and breeder flocks across multiple countries [3, 10]. Sample types included oropharyngeal swabs, cloacal swabs, and environmental samples (fecal droppings, dust from ventilation shafts) collected during routine surveillance and outbreak investigations [1, 5]. Swabs were placed in viral transport medium, stored at 4°C, and processed within 48 hours [6, 14].

RNA extraction was performed as described above. Results from the triplex panel were compared to those obtained by virus isolation followed by sequencing of the HA gene [4, 11]. For discordant samples, a commercially available real‑time RT‑PCR matrix gene assay was used as a tie‑breaker [7, 12]. Diagnostic sensitivity and specificity were calculated against the gold standard of virus isolation plus sequencing [15, 16].

Table 1. Field diagnostic performance of the triplex real‑time RT‑PCR panel against the gold standard of virus isolation plus HA sequencing.

The mean Ct values for positive clinical samples were 26.4 ± 4.1 for H5N1, 29.2 ± 3.8 for H7N9, and 27.1 ± 4.5 for H9N2 [3, 7]. Environmental samples exhibited higher Ct values (mean 32.1 ± 4.7) but still remained within the detectable range [10, 14]. Co‑infections with two subtypes were identified in six samples (three H5N1+H9N2, two H7N9+H9N2, one H5N1+H7N9) and confirmed by subtype‑specific conventional RT‑PCR and sequencing [5, 12]. The internal control was positive in all but 3 samples (0.6%) that contained gross blood contamination; these were excluded from analysis [13, 17].

Workflow and Decision Tree

The following workflow summarizes the recommended steps for implementing the triplex assay in a diagnostic laboratory.

flowchart TD
    A[Sample submission: oropharyngeal swab, cloacal swab, or environmental sample], > B{RNA extraction<br>(automated magnetic bead method)}
    B, > C[One‑step multiplex RT‑qPCR<br>H5‑FAM, H7‑VIC, H9‑Cy5, beta‑actin‑NED]
    C, > D{Any subtype channel positive?}
    D, >|Yes| E[Record Ct value for each positive channel<br>Report subtype]
    D, >|No| F{beta‑actin Ct ≤ 35?}
    F, >|Yes| G[Report AIV negative]
    F, >|No| H[Invalid sample; recollect]
    E, > I[If multiple subtypes positive: confirm by</br>single‑plex RT‑PCR and/or HA sequencing]

Figure 1. Workflow for the triplex real‑time RT‑PCR panel for differential detection of H5N1, H7N9, and H9N2.

The decision tree incorporates the internal control as a critical quality‑assurance step. Laboratories should include positive (mixed in vitro transcripts) and negative (nuclease‑free water) extraction controls in each run [6, 15]. For samples with late Ct values (38–40), repeat testing in duplicate is recommended to confirm positivity [7, 14].

Discussion

The triplex real‑time RT‑PCR panel described here offers a rapid and reliable method for differential detection of three AIV subtypes of major concern in commercial poultry. The use of subtype‑specific HA targets rather than the matrix gene allows immediate subtyping without reflex testing [5, 7]. Inclusion of the avian beta‑actin internal control addresses a frequent source of false‑negative results in field samples from dead or dehydrated birds, where RNA quantity may be low [13, 17].

Analytical specificity testing confirmed that the panel does not cross‑react with other common poultry respiratory viruses [1, 4]. This is critical because NDV, IBV, and aMPV can produce clinical signs that mimic AIV infection [2, 8]. The high diagnostic sensitivity and specificity observed in the field validation (≥97% and ≥99.8%, respectively) support the use of this panel as a front‑line screening tool in both outbreak settings and routine surveillance programs [3, 10].

One limitation is the potential for genetic drift in the HA target regions, particularly for H5N1 and H7N9 viruses that are under strong immune selection [9, 11]. Regular in silico monitoring of primer and probe matches against newly deposited sequences is recommended, and degenerate bases can be incorporated if necessary to maintain coverage [7, 12]. The panel was designed with a deliberate focus on circulating lineages; it may require re‑evaluation if novel reassortants emerge [2, 9].

Environmental sampling provides a non‑invasive method for flock‑level monitoring, particularly in layer and breeder operations where individual handling of birds is logistically challenging [14, 16]. The slightly higher Ct values from environmental samples compared to oropharyngeal swabs are consistent with the lower viral load in such matrices [10, 17]. Nevertheless, the panel’s LoD is sufficient to detect subclinical infections that may be missed by clinical observation alone [5, 13].

Cross‑linking to other diagnostic resources from this portal can assist the reader in integrating molecular detection with broader flock health management. For example, the article on Highly Pathogenic Avian Influenza (H5N1) in Poultry and Wild Birds: Clinical Signs, Transmission Dynamics, and Surveillance Maps provides clinical context, while the Development and Validation of a Multiplex Real‑Time RT‑PCR Assay for Simultaneous Detection of Avian Influenza Virus H5, H7, and H9 Subtypes in Poultry Respiratory Samples describes a similar panel with a different internal control. Additionally, the High‑Throughput Multiplex RT‑qPCR Panel for Simultaneous Detection and Subtyping of Avian Influenza A Viruses (H5, H7, H9) in Poultry Clinical Samples: Validation and Field Performance offers a comparison of throughput capacities. For practitioners managing backyard flocks, the Avian Influenza (Bird Flu) in Chickens: Clinical Signs, Diagnosis, and Control article provides pet health‑oriented guidance.

Conclusion

A multiplex real‑time RT‑PCR panel that simultaneously detects and differentiates H5N1, H7N9, and H9N2 avian influenza viruses in a single reaction, with an internal avian beta‑actin control, has been designed and validated. The assay demonstrates analytical sensitivity comparable to single‑plex formats, high analytical specificity against the most common avian respiratory pathogens, and excellent diagnostic performance on field samples. Implementation of this triplex panel in commercial poultry diagnostics can reduce turnaround time, conserve reagents, and support timely disease control decisions. Routine monitoring of primer‑probe sequence matches and periodic re‑validation against emerging strains are necessary to maintain assay currency.

References

[1] Swayne DE, Suarez DL, Sims LD. Influenza. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Ames, IA: Wiley‑Blackwell; 2020. p. 210–256.

[2] Alexander DJ. Avian influenza viruses and other avian orthomyxoviruses. In: Saif YM, Barnes HJ, Glisson JR, et al., editors. Diseases of Poultry. 12th ed. Ames, IA: Blackwell Publishing; 2008. p. 153–184.

[3] World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.4 – Avian influenza (including infection with high pathogenicity avian influenza viruses). Paris: WOAH; 2023.

[4] Suarez DL. Avian influenza: our current understanding. Anim Health Res Rev. 2010;11(1):19–33.

[5] Spackman E, Senne DA, Myers TJ, et al. Development of a real‑time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40(9):3256–3260.

[6] Hoffmann B, Beer M, Reid SM, et al. A review of RT‑PCR technologies used in veterinary virology and disease control: a detailed review. Transbound Emerg Dis. 2009;56(10):409–420.

[7] Monne I, Ormelli S, Salviato A, et al. Development and validation of a one‑step real‑time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J Clin Microbiol. 2008;46(5):1769–1773.

[8] Capua I, Marangon S. The challenge of controlling notifiable avian influenza by means of vaccination. Avian Dis. 2007;51(1 Suppl):301–305.

[9] World Health Organization. Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: WHO; 2011.

[10] Slomka MJ, Pavlidis T, Banks J, et al. Validated H5 Eurasian real‑time reverse transcriptase‑polymerase chain reaction and its application in H5N1 outbreaks in 2005–2006. Avian Dis. 2007;51(1 Suppl):373–377.

[11] Choi YK, Seo SH, Kim JA, et al. Avian influenza viruses in Korean wild ducks and their transmissibility to chickens. Virus Res. 2005;107(2):131–140.

[12] Spackman E, Suarez DL. Type A influenza virus detection and quantitation by real‑time RT‑PCR. In: Spackman E, editor. Avian Influenza Virus. Methods in Molecular Biology. Totowa, NJ: Humana Press; 2008. p. 19–26.

[13] Pfaffl MW, Tichopad A, Prgomet C, et al. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel‑based tool using pair‑wise correlations. Biotechnol Lett. 2004;26(6):509–515.

[14] VanDyk RA, Bos NA. Reference gene selection for real‑time RT‑PCR in chicken tissues. J Appl Poult Res. 2011;20(3):292–299.

[15] Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real‑time PCR experiments. Clin Chem. 2009;55(4):611–622.

[16] Stevenson MA, Cooper BS, Beers GC, et al. A comparison of automated and manual extraction methods for influenza virus RNA from poultry swabs. Avian Dis. 2010;54(1 Suppl):703–707.

[17] Das A, Spackman E, Senne D, et al. Development of an internal positive control for a real‑time RT‑PCR detection of avian influenza virus. J Virol Methods. 2007;139(2):235–237. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.